Hepatitis B virus and blood transfusion safety in Sub-Saharan Africa

Internet Journal of Infectious Diseases

Volumn 7, Issue 2, 2010, Pages 16-

  Ogbu, Ogbonnaya ^a   Uneke, Chigozie Jesse ^a  

^a EBONYI STATE UNIVERSITY   (Nigeria)

Author keywords

Blood; Hepatitis B virus; Sub Saharan Africa; Transfusion

Indexed keywords

HEPATITIS B(E) ANTIGEN; RNA DIRECTED DNA POLYMERASE;

AFRICA; BLOOD DONOR; BLOOD TRANSFUSION; DNA SYNTHESIS; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; INCUBATION TIME; MUTATION RATE; PREVALENCE; PUBLIC HEALTH; REVIEW; SAFETY; VIRAL CONTAMINATION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 77953457638     PISSN: None     EISSN: 15288366     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Drosten C, Nippraschk T, Manegold C et al. Prevalence of hepatitis B virus DNA in anti-HBC-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus. J Clin Virol 2004; 29: 59-68.
2. Beasley, R. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cance 1988; 61:1942-56.
3. Evans AA, London WT. Epidemiology of hepatitis B. In Zuckerman AJ, Thomas HC, editors. Viral hepatitis. Harcourt Brace & Co., Ltd., London, United Kingdom. 1998. p. 107-14.
4. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80:827-41.
5. Chan HLY, Lok ASF. Hepatitis B in adult-a clinical perspective. Clin Liver Dis 1999; 3(2): 291-307.
6. Mahoney FJ, Long SS, Pickering LK. Hepatitis B virus. In: Principles and Practice of Pediatric Infectious Diseases. 1997: 1194-202.
7. McMahon BJ, Alward WLM, Hall DB et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603.
8. Beasley RP, Heang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981; 318: 1129-1133.
9. Pyrsopoulos NT. Hepatitis B. e-Medicine. 2007. Available at: http://www.emedicine.com/med/TOPIC992.HTM. Accessed March 10th, 2008
10. Poonam Sharma. Hepatitis B. e-Medicine. 2008. Available at: http://www.emedicine.com/ped/TOPIC978.HTM. Accessed May 5th, 2008.
11. Seeger C, Mason SW. Hepatitis B virus biology. Microbiol Molec Biol Rev 2000; 64 (1): 51-68
12. Ganem D, Pollack JR, Tavis J. Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. Infect Agents Dis 1994; 3:85-93.
13. Seeger C, Mason WS. Replication of the hepatitis virus genome,. In DePamphilis ML, editors. DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.1996. p. 815-31
14. Kuhns MC, McNamara AL, Holzmayer V, Lou SC, Busch MP. Frequency of Diagnostically Significant Hepatitis B Surface Antigen Mutations. American Association for Clinical Chemistry Annual Meeting, Chicago, Illinois, July 23-27, 2006
15. Maynard JE, Kane MA, Alter MJ, Hadler SC. Control of hepatitis B by immunization: global perspectives. In: Zuckerman AJ, editor. Viral hepatitis and liver disease. New York: Alan R. Liss, Inc., 1988. p. 967-9.
16. McMahon BJ, Alward WLM, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1984;151: 599-603.
17. Beasley RP, Hwang LY, Lee GCY, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-102.
18. Fattovich G, Brollo L, Giustina G. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32(3): 294-8.
19. Centre for Disease Control and Prevention. Public Health Service Inter-Agency Guidelines for Screening Donors of Blood, Plasma, Organs, Tissues, and Semen for Evidence. MMWR 1991; 40(RR-4): 1-17.
20. Saha V, John TJ, Dhamodaran S, Carman RH. Highly sensitive screening tests for hepatitis B surface antigen in transfusion centres of developing countries. Br Med J 1988;297:646-7.
21. Ndumbe PM, Nyouma E. Transmission of hepatitis B virus by blood transfusion in Yaounde, Cameroon. Br Med J. 1990;301:523-524.
22. Sarkodie F, Adarkwa M, Candotti D, Acheampong JW, Allain JP. Screening for viral markers by EIA in volunteer and replacement donors in Kumasi, Ghana. Vox Sang 2001;80:142-147.
23. Allain JP, Candotti D, Soldan K et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003; 101(6):2419-25.
24. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz 2005;100(1):13-6.
25. Ejele OA, Ojule AC. The prevalence of hepatitis B surface antigen (HBsAg) among prospective blood donors and patients in Port Harcourt, Nigeria. Niger J Med 2004;13(4):336-8.
26. Oronsaye FE, Oronsaye JI. Prevalence of HIV-positives and hepatitis B surface antigen-positives among donors in the University of Benin Teaching Hospital, Nigeria. Trop Doct 2004;34(3):159-60.
27. Otegbayo JA, Fasola FA, Abja A. Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria Trop Gastroenterol 2003;24(4):196-7.
28. Harry TO, Bajani MD, Moses AE. Hepatitis B virus infection among blood donors and pregnant women in Maiduguri, Nigeria. East Afr Med J 1994;71(9):596-7.
29. Ekpo M, Sasegbon H, Oyewole F. HIV and HBV serostatus of non-intravenous drug users in Lagos, Nigeria. Nig Med J 1995; 29: 35-6.
30. Collenberg E, Ouedraogo T, Ganame J et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol 2006;78(5):683-92.
31. Matee MI, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 2006; 6:21.
32. Dray X, Dray-Spira R, Bronstein JA, Mattera D. Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti. Med Trop (Mars). 2005;65(1):39-42.
33. Uneke CJ, Ogbu O, Nwojiji V. Potential risk of induced malaria by blood transfusion in South-eastern Nigeria. MJM 2006; 9:8-13.
34. Soldan K, Davison K, Dow B. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Euro Surveill 2005;10(2):17-9
35. Liu CJ, Chen DS, Chen PJ. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006;36 Suppl 1:S33-44
36. Jongerius JM, Wester M, Cuypers HT et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 1998; 38: 56-9.
37. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997; 4 (Suppl 1): 11-20.
38. Carman WF, Mimms LT. Pre-S/S gene variants of hepatitis B virus. In: Rizzetto M, Purcell RH, Gerin JL, Verne G, editors. Viral hepatitis and liver disease. Torino, Italy: Edizioni Minerva Medica; 1997. p. 108-15.
39. Tsai S, Liaw Y, Yeh C, Chu CM, Kuo GC. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus. Hepatology 1995; 21: 908-12.
40. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
41. Ben Ayed M, Triki H, Cointe D et al. The isolated presence of anti-HBc antibodies: prevalence and interpretation based on the results of viral DNA research and anti-HBs antibodies measurement after vaccination. Ann Biol Clin (Paris) 2001; 59: 53-60.
42. Gomes SA, Yoshida CF, Niel C. Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions. Acta Virol 1996; 40: 133-8.
43. Iizuka H, Ohmura K, Ishijima A et al. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63: 107-11.
44. Saraswat S, Banerjee K, Chaudhury N et al. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol 1996; 25: 639-43.
45. Kitchen A. Hepatitis B and blood safety. Vaccine 1998; 16 Suppl:S34-7.
46. Akhtar S, Younus M, Adil S, Hassan F, Jafri SH. Epidemiologic study of chronic hepatitis B virus infection in male volunteer blood donors in Karachi, Pakistan. BMC Gastroenterol 2005;5:26
47. Panhotra BR, Al-Bahrani A, Ul-Hassan Z. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing. Saudi Med J 2005;26(2):270-3